Daniel Canos, Director, Office of Clinical Evidence and Analysis, OPEQ, CDRH at FDA

Daniel Canos

Director, Office of Clinical Evidence and Analysis, OPEQ, CDRH at FDA | Washington DC-Baltimore Area, United States

Profile last verified July 2026
Government Administration Verified Profile Washington DC-Baltimore Area, United States University of North Carolina at Chapel Hill
Verified

Work Email

***@mhg.edu

Last verified August 2026

Personal Email

***@icloud.com

Personal • High Confidence

Phone Number

301*****

United States • Mobile

Free account · No credit card · 5 profiles/month

Daniel Canos Socials
Daniel Canos Work Experience

Director, Office of Clinical Evidence and Analysis, OPEQ, CDRH at FDA in April 2020 - Present

Deputy Director, Office of Clinical Evidence and Analysis, OPEQ, CDRH at FDA in March 2019 - April 2020

Director, Evidence Development Division, Coverage and Analysis Group at Centers for Medicare & Medicaid Services in March 2018 - March 2019

See more See less

Senior Epidemiologist in the Center for Clinical Standards and Quality, Coverage and Analysis Group at Centers for Medicare & Medicaid Services in January 2016 - March 2018

Senior Epidemiologist (Detail)in the Office of Surveillance and Biometrics, CDRH at FDA in January 2016 - March 2018

Senior Epidemiologist (Detail) in Center for Clinical Standards and Quality, Coverage & Analysis Grp at Centers for Medicare & Medicaid Services in March 2015 - January 2016

Associate Director, Division of Epidemiology, CDRH at FDA in January 2013 - January 2016

Branch Chief, Division of Epidemiology, CDRH at FDA in November 2011 - January 2013

Team Leader, Division of Epidemiology, CDRH at FDA in September 2009 - October 2011

Division of Epidemiology, Staff Fellow at FDA in May 2008 - September 2009

Research Assistant at University of North Carolina at Chapel Hill in August 2004 - May 2008

Research Analyst at MedStar Health in September 2001 - August 2004

Daniel Canos Education

University of North Carolina at Chapel Hill, Doctor of Philosophy (PhD)

St. X

The George Washington University, Master of Public Health (MPH), January 1999 to January 2001

See more See less

University of Cincinnati, Bachelor of Arts (BA), January 1995 to January 1998

Daniel Canos Skills
Epidemiology Research Public Health Biostatistics Global Health SAS Program Evaluation Data Analysis Statistics Literature Reviews Clinical Trials Clinical Research Statistical Modeling Prevention Grant Writing Clinical Study Design Stata Teaching
About Daniel Canos’s Current Company
FDA

The Food and Drug Administration is an agency within the Department of Health and Human Services. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation. FDA also has responsibility for regulating the manufacturing, marketing, and distribution of tobacco products to protect the public health and to reduce tobacco use by minors. FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health. FDA also plays a significant role in the Nation's counterterrorism capability. FDA fulfills this responsibility by ensuring the security of the food supply and by fostering development of medical products to respond to deliberate and naturally emerging public health threats.

Discover more about FDA
Daniel Canos’s Colleagues
Quentin Moore

Quentin Moore

Toledo, Ohio Metropolitan Area

Aidoc | Ex-FDA | Regulatory Expert AI/ML Medical Imaging SaMD

Director, Regulatory Affairs at Aidoc
(April 2025 – Present)

Ricki Chase

Ricki Chase

Chicago, Illinois, United States

Ex-FDA | Consultant | Strategist | Dynamic Quality and Compliance Leader

President at R. Chase Consulting LLC
(April 2023 – Present)

Kevin Bugin

Kevin Bugin

Washington DC-Baltimore Area

Head of Global Regulatory Policy and Intelligence at Amgen

Adjunct Faculty at The George Washington University School of Medicine and Health Sciences
(December 2016 – Present)

Christine Leeflemming

Christine Leeflemming

Washington DC-Baltimore Area

Former FDA Acting Associate Commissioner for Minority Health and Deputy Office Director

Former FDA Acting Associate Commissioner for Minority Health and Deputy Office Director at FDA
(December 2023 – Present)

Salman H

Salman H

Washington DC-Baltimore Area

Clinical Analyst (Clinical Safety Review) at Office of New Drugs/CDER/US FDA

Co-Founder at NexTop-USA
(January 2011 – Present)

Stephanie Val

Stephanie Val

Cambridge, Massachusetts, United States

Regulatory CMC | Cell & Gene Therapy

Gene Therapy CMC Reviewer at FDA
(November 2023 – Present)

Search similar profiles
Frequently asked questions about Daniel Canos

What is Daniel Canos email address?

Email Daniel Canos at [email protected] and [email protected]. This email is the most updated Daniel Canos's email found in 2026.

What is Daniel Canos phone number?

Daniel Canos phone number is 301-796-6057.

How to contact Daniel Canos?

To contact Daniel Canos send an email to [email protected] or [email protected]. If you want to call Daniel Canos try calling on 301-796-6057.

What company does Daniel Canos work for?

Daniel Canos works for FDA.

What is Daniel Canos's role at FDA?

Daniel Canos is Director, Office of Clinical Evidence and Analysis, OPEQ, CDRH

What industry does Daniel Canos work in?

Daniel Canos works in the Government Administration industry.

Find anyone, anywhere
with ContactOut today

Making remote or global hires? Connecting
with key decision-makers? We can help.

  • 40 emails / month
  • 3 phone numbers / month
  • Works on standard LinkedIn only
  • Work emails, personal emails,
    mobile numbers
* 1 user per company limit

No credit card required

Try ContactOut for Free